Cure Alzheimer's Fund Cure Alzheimer's Fund

Kevin Rynearson, B.S., M.S., Ph.D.

Assistant Project Scientist, Neurosciences, University of California, San Diego

Dr. Rynearson is a Project Scientist in the Department of Neurosciences at the University of California, San Diego (UCSD) School of Medicine. He received his B.S. in Chemistry from San Diego State University. Subsequently, Dr. Rynearson earned his M.S. and Ph.D. in Chemistry at UCSD under the supervision of Dr. Thomas Hermann, conducting research aimed at developing novel small molecules biased for interaction with therapeutically relevant RNA targets. From there, Dr. Rynearson received Postdoctoral training in translational medicine, pharmacology, and drug discovery in the laboratory of Dr. Steven Wagner. Currently, his research focuses on the development of gamma-secretase modulators as a potential treatment for Alzheimer’s disease (AD) and has reached Phase I clinical trials. His research is also interested in identifying alternative and complementary therapeutic approaches for AD. Dr. Rynearson is continuing the tremendous work of his mentor, Dr. Steven L. Wagner.

 

 

Related Research:

Funded Research

These projects were made possible from Cure Alzheimer's Fund support.

Project Description Researchers Funding
Continuing Studies of the Effects of GSM 776890 Administration on Amyloid Species and Microgliosis in Older Alzheimer’s Model Mice 2021

$291,374

Back to Our Researchers